StockWatch
·
Biotechnology: Pharmaceutical Preparations
Loan & DebtJun 2, 2026, 08:02 AM

Gossamer Bio Extends Early Tender Deadline for Convertible Notes Exchange

AI Summary

Gossamer Bio, Inc. announced the extension of the early tender deadline for its exchange offer and consent solicitation regarding its 5.00% Convertible Senior Notes due 2027. The new deadline is June 2, 2026, with an expected early settlement date of June 4, 2026. As of June 1, 2026, $181,052,000 in existing convertible notes had been tendered, with a minimum condition of 98% of the aggregate principal amount required for the exchange offer. The offer involves exchanging existing notes for new 7.50% Convertible Senior Secured First Lien Notes due 2030, common stock, or prefunded warrants, and purchase warrants.

Key Highlights

  • Gossamer Bio extended the early tender deadline for its exchange offer to June 2, 2026, 5:00 p.m.
  • The expected early settlement date for the exchange offer is now June 4, 2026.
  • $181,052,000 in Existing Convertible Notes were tendered as of June 1, 2026.
  • The exchange offer requires a minimum tender of 98% of the aggregate principal amount of Existing Convertible Notes.
  • The offer includes up to $72.0 million in new 7.50% Convertible Senior Secured First Lien Notes due 2030.
  • The offer also includes up to 317,647,058 shares of common stock or prefunded warrants.
  • The Expiration Deadline for the Exchange Offer remains June 16, 2026.